Santa Fe, NM, United States of America

Michael Frank Erasmus

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Michael Frank Erasmus: Innovator in Antibody Library Development

Introduction

Michael Frank Erasmus is a prominent inventor based in Santa Fe, NM (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries. With a total of 8 patents to his name, Erasmus has established himself as a key figure in advancing antibody technology.

Latest Patents

Erasmus's latest patents focus on antibody libraries with maximized antibody developability characteristics. These libraries comprise a plurality of heavy chain variable domains and/or light chain variable domains, which include complementary determining regions (CDRs) found in naturally-occurring human antibodies. The methods of making such antibody libraries ensure that they are free of members that comprise one or more liabilities affecting their features. Furthermore, these libraries include members with heavy chain and/or light chain CDRs not found in the same naturally-occurring human antibody.

Career Highlights

Throughout his career, Michael Frank Erasmus has worked with notable companies such as Rules-Based Medicine, Inc. and Specifica Inc. His work has significantly impacted the biotechnology sector, particularly in the development of innovative solutions for antibody applications.

Collaborations

Erasmus has collaborated with several professionals in his field, including Andrew Raymon Morton Bradbury and Andre Teixeira. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Michael Frank Erasmus is a distinguished inventor whose work in antibody library development has paved the way for advancements in biotechnology. His innovative patents and collaborations highlight his commitment to enhancing the field and improving antibody applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…